Coldstream Capital Management Inc. Buys 1,650 Shares of Aflac Incorporated (NYSE:AFL)

Coldstream Capital Management Inc. raised its position in shares of Aflac Incorporated (NYSE:AFL) by 2.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 64,586 shares of the financial services provider’s stock after purchasing an additional 1,650 shares during the period. Coldstream Capital Management Inc.’s holdings in Aflac were worth $6,681,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of AFL. Whipplewood Advisors LLC purchased a new stake in shares of Aflac in the fourth quarter worth about $26,000. BankPlus Trust Department purchased a new stake in Aflac in the 4th quarter worth approximately $34,000. Curio Wealth LLC purchased a new stake in Aflac in the 4th quarter worth approximately $36,000. OFI Invest Asset Management bought a new position in Aflac in the 4th quarter valued at $38,000. Finally, Rialto Wealth Management LLC purchased a new position in shares of Aflac during the 4th quarter valued at $41,000. 67.44% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Aflac

In related news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the sale, the director now owns 49,962 shares in the company, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms recently issued reports on AFL. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. BMO Capital Markets assumed coverage on Aflac in a research report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price target for the company. Keefe, Bruyette & Woods decreased their price objective on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research report on Wednesday, February 12th. Morgan Stanley dropped their target price on shares of Aflac from $105.00 to $100.00 and set an “equal weight” rating for the company in a research report on Thursday, April 10th. Finally, JPMorgan Chase & Co. increased their price target on shares of Aflac from $94.00 to $96.00 and gave the stock a “neutral” rating in a report on Wednesday, April 2nd. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Aflac presently has an average rating of “Hold” and a consensus target price of $103.93.

Aflac Trading Down 1.1 %

Shares of AFL stock opened at $107.96 on Friday. The business has a 50-day moving average of $107.14 and a 200 day moving average of $107.13. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. Aflac Incorporated has a 1-year low of $80.59 and a 1-year high of $115.50. The stock has a market capitalization of $58.93 billion, a PE ratio of 11.25, a P/E/G ratio of 3.24 and a beta of 0.81.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, sell-side analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.